{"id":938289,"date":"2026-02-19T12:56:31","date_gmt":"2026-02-19T17:56:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/"},"modified":"2026-02-19T12:56:31","modified_gmt":"2026-02-19T17:56:31","slug":"alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/","title":{"rendered":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Feb.  19, 2026  (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology\u201d; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit.<\/p>\n<p>The details of the meetings are as follows:<\/p>\n<p>\n        <strong>Wells Fargo Executive Biotech Summit<\/strong>\n      <\/p>\n<p>Format: One-on-one meetings<br \/>Date: February 24-25, 2026<br \/>Location: Lake Tahoe, CA<\/p>\n<p>\n        <strong>TD Cowen 46th Annual Health Care Conference <\/strong>\n      <\/p>\n<p>Format: Presentation<br \/>Date: March 3, 2026<br \/>Time: 9:10 AM EST<br \/>Location: Boston, MA<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_1T28wdXVcSJnd_Cs3y9DItfvK7w5ayR0aotLNtdDj4H-x0ZUN1Njz3zwmVw0gioUazEgam8SxRDRm0bxWbQXVEbl19gVd7P_cXSfBanH-O7DXu5vpnK4uWr0qIZAfUk2UtAQzjuvId0OciITCGxcQ==\" rel=\"nofollow\" target=\"_blank\"> here<\/a><\/p>\n<p>\n        <strong>UBS Biotech Summit<\/strong>\n      <\/p>\n<p>Format: One-on-one meetings<br \/>Date: March 10, 2026<br \/>Location: Miami, FL<\/p>\n<p>The webcast of the TD Cowen 46th Annual Health Care Conference presentation can be accessed by visiting the Investors section of ALX Oncology\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rULxZexCT-cXUshYRfKeS2foGudI1ObfDfPp2c1CFl4ry6ydetdXvkmOTqNUlzJGCFmj5JhVDsBWFTWKDrQCAzS5G9J86yEOL9tjFh-dBMs=\" rel=\"nofollow\" target=\"_blank\">www.alxoncology.com<\/a> under the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mEEywv48NBwvgu00GWh8Ev3Nog9dUC3wRpG5o1RaTWToXc67Uubqw-rdmgyoS63pHtJv3k5ZcBX7bZHhRU4XV0_He1JG_lG6NyvqW2A7_Q8RxBb3cIDB3Kdzx6g8HA7P\" rel=\"nofollow\" target=\"_blank\">Events<\/a> section of the Events and Presentations tab. Replay of the webcast will be archived for up to 90 days following the presentation date.<\/p>\n<p>\n        <strong>About ALX Oncology<\/strong><br \/>\n        <br \/>ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology\u2019s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action. A Phase 1 dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors. More information is available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rULxZexCT-cXUshYRfKeS7rFvQ-6E0_ZN0xSfO-4KxRXIOkHlTCevs2G30zdj5RSupGkA1NlGvQK5-F_UJfPolX_exKGeT7Y_SNlpmHrh9mrjRvJOLz5XGrA6r4jpetTneIL-AB1g4N8_TFfYULxYf0XIzfLizPbupiJO9mlO2QbSh1sz2hC1lcoHm-sgvqHYkTDAne7ACWj0q_FslpdZazes-pzqoE-lRiYLNtJ7bcUJhKJqUJtAS0HllwL5OOzfoaKqK61PDaQtPEM7H53eg==\" rel=\"nofollow\" target=\"_blank\">www.alxoncology.com<\/a>\u00a0and on LinkedIn\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2p5mOO0-dIQp9ic6qBjEBHrlwueeiLR4O8eX-Agq3EJomcKtpUuzsnbJyU0u2NdfIwfxLrCaWMqfzYWIVAbhI6_3EeVRw0GnNgNt49mPiaem-xonpaO0vQtNAHnOfsy8\" rel=\"nofollow\" target=\"_blank\">@ALX Oncology<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Elhan Webb, CFA, IR Consultant<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k8Dt89OPpl-l1pN0Ws4L-eYmHxLvIt5t5S7a5S6VQ77cmesqBktPwihUdwICa1IuKBJiXg2Clkv37mFSJIbhiBN8UtMu5KHdHZ5fqlJEV8SuXfr2kwZd32rhohtH_NMd64SxV2cPdnZg0KwkuTq0nQR56my2nEEIweY1TvhZBXXYJ5NErRHLDzYDOr3R59IsyxccByZabvHehDxOo6TuL7o8qGJ2jjxwYesDLQEWtdjvkcus5BsNFoYrxQtHlXyUwSAYK7Xh3z8NPZWN9p97NQ==\" rel=\"nofollow\" target=\"_blank\">ewebb@alxoncology.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Michele Parisi, SparkPoint Healthcare Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QOyuXYuPG9c8wTxXP-PPFrVZolvWmb5XfsD7gi7yUgO5x1XY7x5B0BvT02FF9Xb1C7l19u6mpghnze-A1UnW2Qf_-Om2uhSD7Q9Y_eahD6RtPTJBPVvR_dTmTqqebl0l\" rel=\"nofollow\" target=\"_blank\">mparisi@sparkpointpr.com<\/a>\u00a0<br \/>(925) 864-5028<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhlOTA0YmMtNTQ3OC00NDQyLTgwNTUtZmUzMGVmY2JkZTZhLTEyMDQ0MTYtMjAyNi0wMi0xOS1lbg==\/tiny\/ALX-Oncology.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology\u201d; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit. The details of the meetings are as follows: Wells Fargo Executive Biotech Summit Format: One-on-one meetingsDate: February 24-25, 2026Location: Lake Tahoe, CA TD Cowen 46th Annual Health Care Conference Format: PresentationDate: March 3, 2026Time: 9:10 AM ESTLocation: Boston, MAWebcast link: Available here UBS Biotech Summit Format: One-on-one meetingsDate: March 10, 2026Location: Miami, FL The webcast of the TD &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-938289","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology\u201d; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit. The details of the meetings are as follows: Wells Fargo Executive Biotech Summit Format: One-on-one meetingsDate: February 24-25, 2026Location: Lake Tahoe, CA TD Cowen 46th Annual Health Care Conference Format: PresentationDate: March 3, 2026Time: 9:10 AM ESTLocation: Boston, MAWebcast link: Available here UBS Biotech Summit Format: One-on-one meetingsDate: March 10, 2026Location: Miami, FL The webcast of the TD &hellip; Continue reading &quot;ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T17:56:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026\",\"datePublished\":\"2026-02-19T17:56:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/\",\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\",\"datePublished\":\"2026-02-19T17:56:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/","og_locale":"en_US","og_type":"article","og_title":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc. (&#8220;ALX Oncology\u201d; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients\u2019 lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit. The details of the meetings are as follows: Wells Fargo Executive Biotech Summit Format: One-on-one meetingsDate: February 24-25, 2026Location: Lake Tahoe, CA TD Cowen 46th Annual Health Care Conference Format: PresentationDate: March 3, 2026Time: 9:10 AM ESTLocation: Boston, MAWebcast link: Available here UBS Biotech Summit Format: One-on-one meetingsDate: March 10, 2026Location: Miami, FL The webcast of the TD &hellip; Continue reading \"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-19T17:56:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026","datePublished":"2026-02-19T17:56:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/","name":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=","datePublished":"2026-02-19T17:56:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NzM3OSM3NDMzODA1IzIxOTI4NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-to-present-at-upcoming-investor-conferences-in-q1-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=938289"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938289\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=938289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=938289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=938289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}